Literature DB >> 26879523

The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis.

Y-T Chen1,2, W-T Tu1, W-R Lee1,3, Y-C Huang3,4.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a rare and locally aggressive tumour, with a high recurrence rate, even after complete surgical excision. Adjuvant radiotherapy (RT) has been suggested to reduce the risk of local recurrence after inadequate surgical resection in patients with narrow or positive surgical margins. However, the overall efficacy of adjuvant RT has not been well studied because of the rarity of DFSP and lack of an appropriate comparison group.
OBJECTIVE: We sought to evaluate the efficacy of adjuvant RT for DFSP by conducting a systemic review and meta-analysis to provide a more evidence-based measure of its effectiveness.
METHODS: We conducted a systemic review of articles published before 31 June 2015. Due to the rarity of the disease, we included all studies that reported DFSP patients who received adjuvant RT (postoperatively). The pooled recurrence rates were analysed from these extracted data.
RESULTS: Twelve studies met the inclusion criteria. The pooled estimate of the recurrence rate for all adjuvant radiotherapy was 11.74% (95% CI 7.4-17.38; n = 167). Patients with positive/close had a pooled recurrence rate of 14.23% (95% CI 8.13-22.49; n = 92), whereas there was no recurrence in patients with negative margins. The pooled estimate of the recurrence rate between surgery alone and surgery combined with adjuvant radiotherapy showed no significant difference (odds ratio 0.31, P = 0.07), although there was a trend that adjuvant RT had a lower recurrence rate than surgery alone.
CONCLUSION: Adjuvant RT might be considered for all patients undergoing surgical excision, even if a negative surgical margin has been achieved. Furthermore, for patients with large or recurrent tumours, especially when wide excision with negative margin would result in a significant functional or cosmetic deficit, postoperative radiotherapy is highly recommended in order to achieve a lower recurrence rate.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 26879523     DOI: 10.1111/jdv.13601

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

Review 1.  Dermatofibrosarcoma Protuberans.

Authors:  Alvaro E Acosta; Catalina Santa Vélez
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

Review 2.  Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.

Authors:  Takeshi Iwasaki; Hidetaka Yamamoto; Yoshinao Oda
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

3.  Dermatofibrosarcoma of The Breast - Case Report and Review of Literature.

Authors:  Amr Muhammed; Esraa Elnakib; Mahmoud Nady
Journal:  Eur J Breast Health       Date:  2018-10-01

4.  Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis.

Authors:  Kaixin Du; Jinluan Li; Lirui Tang; Xiaoyi Lin; Xiangquan Kong; Xuehong Liao; Qingqin Peng; Yaping Dong; Junyan He; Yunxia Huang; Xueqing Zhang; Feifei Lin; Qingyang Zhuang; Junxin Wu
Journal:  Radiat Oncol       Date:  2019-01-29       Impact factor: 3.481

Review 5.  A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature.

Authors:  Yihua Wang; Yu Wang; Rui Chen; Zhenrong Tang; Shengchun Liu
Journal:  Biomed Res Int       Date:  2020-11-09       Impact factor: 3.411

6.  Multidisciplinary Approach to the Management of Extensive Dermato-fibro-sarcomas Involving the Chest Wall.

Authors:  Wanjala F Nangole; M Muhinga
Journal:  Indian J Plast Surg       Date:  2020-08-20

7.  Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review.

Authors:  Jian-Xia Xiong; Tao Cai; Li Hu; Xiao-Li Chen; Kun Huang; Ai-Jun Chen; Ping Wang
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

8.  Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.

Authors:  Jessica Beaziz; Maxime Battistella; Julie Delyon; Cécile Farges; Oren Marco; Cécile Pages; Christine Le Maignan; Laetitia Da Meda; Nicole Basset-Seguin; Matthieu Resche-Rigon; Anouk Walter Petrich; Delphine Kérob; Céleste Lebbé; Barouyr Baroudjian
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.